It is well-known that the presence of haemoglobin variants can influence, and even invalidate, measurements of haemoglobin Ale (HbA Ic ) when using ion-exchange or electrophoretic separation techniques. \ We report here an effect of an unusual haemoglobin variant that we believe has not been described before.
A blood specimen from an 88-year-old diabetic man was found to have an apparently low HbA Ic of 2,7°1., (reference range 3·8 -5'5%) when measured by high-performance ion-exchange chromatography (HPIEC) on a Daiichi HA-8121 analyser (Biomen, Fincharnpstead, UK). Examination of the trace revealed an unusual elution profile ( Fig. Ia) compared with the pattern seen in other patients (Fig. Ih) . In particular, an extra peak amounting to 1·2% of the total haemoglobin could be seen between the large HbA o peak and the shaded area representing HbA Ic . This finding was corroborated by analysing the blood sample at the Royal Liverpool University Hospital on a Daiichi HA-8140, which is capable of resolving some of the more common haemoglobin variants such as S, C and D. Another blood specimen from the patient confirmed the atypical pattern. When the original specimen was assayed using an affinity chromatography method (Helena Laboratories, Sunderland, UK) the result was 5,6%, i.e. around the upper limit of normal. Routine haematological parameters were normal.
A blood sample was also subjected to e1ectrospray mass spectrometry (ES-MS) using a Quattro II analyser (Micromass UK, Altrincharn, UK), as previously described." An unusual haemoglobin variant was detected, associated Correspondence: Dr K Wiener. with a 40 Da increase in the mass of the fJ-chain ( Fig. 2) , implying an amino-acid substitution and affecting about 49% of all the fJ-chains. More detailed fragmentary mass analysis suggested that this was caused by Pro~His substitution at fJSI' which, so far as we are aware, has not previously been reported.'
Apart from his diabetes and some intermittent claudication, there was little else of note in this man's medical history, but a blood sample from his grandson showed the same atypical characteristics. Unfortunately, the patient declined to co-operate with further family studies.
DISCUSSION
This 88-year-old man seemed to be suffering no serious consequences from the presence of substantial quantities of an unusual haemoglobin variant in his red cells. Although detailed family studies were not possible, his grandson (his son's son) also had the same variant and both had about half their {i-chains in the variant form, suggesting they were heterozygous for the characteristic. So far as we can see at this stage, the main consequence of its presence seems to be that it invalidates the Hb Aj, measurement, at least by the Daiichi HPIEC method and probably by other similar ionexchange techniques. For this reason we draw it to the attention of those involved in the measurement and use of HbA\c'
It is noteworthy that the low result on HPIEC would not have been quite so obvious if total HbA I had been used instead of HbA le, as the abnormal peak would have been included in the total HbA\ calculation, giving a value of 5·4% (reference range 5·5 to 7·7%). Electrospray mass spectrometry attributed about half of the total fJ-globin chains to the variant, of which approximately 5·7% were glycated. This compared with about 7·0% glycation of the normal {i-chains. If HPlEC recognized only the latter as HbA\c, and treated glycated variant f3-chain simply as part of the total haemoglobin, one might expect it to report a value roughly half of this, i.e. about 3·5%, relative to total haemoglobin. In fact, a slightly lower figure of 2,7°1., was recorded, but some discrepancy would be expected owing to the completely different nature of the two analytical and calculation procedures. ES-MS measures glycation on both 7.-and {i-chains and initial studies suggest nondiabetic subjects have values up to about 4·0% expressed as glycated haemoglobin, rather than as HbA Ic ." For our patient, the ES-MS figure was 4·6% (his grandson's was 3'6%) and would include glycation on the variant {i-chain. Hence, ES-MS is more likely than HPIEC to reflect his true glycaemia status. Indeed, the slightly raised values by ES-MS and by affinity chromatography are more in keeping with what might have been expected from his blood glucose concentrations of around 11·0 rnmol/L measured by the general practitioner. The abnormal peak on the HPIEC trace was presumed to be glycated variant haemoglobin, but the absence of a large peak of unglycated variant suggests that the latter eluted with HhA, and was not detected as a separate peak. This instance serves as a reminder of the importance of examining chromatography traces for abnormalities, rather than simply accepting the integrated values without question.
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Further studies on the variant are underway and, if it is confirmed to be a new one, it is proposed to name it Haemoglobin North Manchester.
